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Two groups of complement components are involved in the activation of C3. 
The first includes C2, factor B (B), C4, and C3, i.e., the structural components 
of the  C3  convertases  of the  classical  and  alternative pathways.  The  second 
contains the regulatory proteins C4-binding protein (C4-bp),  factor H  (H), the 
C3b/C4b receptor (CRI or C3bR), and, probably, the decay-accelerating factor 
(DAF) and gp45-70. 
C2,  C4,  and  factor B  are  encoded by a  cluster of genes  inside the  major 
histocompatibility complex  (MHC), 1 a  genetic  association  that  is  consistently 
found in mammalian species (reviewed in  1 and 2). The mechanisms leading to 
that linkage and its evolutionary stability are unclear, as are its functional and 
genetic consequences. Study of the linkage relationships of other genes that code 
for proteins involved in the activation of C3 is, therefore, of considerable interest. 
We  have  recently demonstrated genetics variants of C4-bp  (3),  H  (4),  and 
C3bR (5,  6)  in humans and have reported that the loci coding for C4-bp and 
C3bR are very closely linked (7).  We proposed (7) the hypothesis that a cluster 
of genes encoded the regulatory complement components of the activation of 
C3.  We now present evidence indicating that the locus coding for factor H  in 
humans is also linked to the C4BP, C3bR cluster. In addition, we show that this 
cluster of regulatory proteins segregates independently of the C2, Bf, C4A, C4B 
gene cluster and of the human C3 locus. 
Materials and Methods 
Materials.  ~-Aminocaproic acid,  Nonidet P-40 (NP-40), /3-mercaptoethanol, phenyl- 
methytsulfonyl fluoride, Coomassie Brilliant Blue R, and neuraminidase type V (Clostrid- 
ium perfringens)  were  from Sigma Chemical Co.,  St.  Louis,  MO;  EDTA from Fisher 
Scientific Co., Pittsburgh,  PA; ampholine (pH 3.5-10, 4-6, and 6-8) from LKB Produk- 
ter,  Bromma,  Sweden;  N,N'-methylenebis-acrylamide,  acrylamide,  N,N,N ',N '-tetra- 
methylethylenediamide,  ammonium persulfate,  sodium dodecyl sulfate (SDS) from Bio- 
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Rad  Laboratories, Richmond, CA;  ultrapure urea from Schwarz-Mann  Biotech, Cam- 
bridge, MA. 
Blood Samples.  230 families were included in these studies. The familial relationships 
were corroborated in all cases  by several genetic polymorphisms. Some of the families 
were made available by Dr. F. Ginsberg-Fellner, Department of Pediatrics, Mount Sinai 
School of Medicine, New York and by Dr. G.  Ercilla,  Departamento de Inmunologia, 
Hospital Clinico y Provincial, Barcelona, Spain. 
Blood samples were obtained by venipuncture, and lymphocytes, EDTA-plasma, and 
serum were separated by standard techniques. Red blood cells were also obtained. Tests 
were done on fresh specimens whenever possible. Otherwise, samples were frozen and 
kept either in the gas phase of liquid nitrogen (lymphocytes and erythrocytes)  or at -80 °C 
(serum and plasma) until used. 
Allotyping of C4-bp and H.  C4BP  and FH phenotyping were performed as previously 
described (8) using EDTA-plasma or EDTA-serum. Briefly, samples were treated with 
neuraminidase, immunoprecipitated with a monospecific antibody, analyzed by isoelectric 
focusing under denaturing conditions using vertical 4.5% polyacrylamide gels, and stained 
with Coomasie Brilliant Blue. 
AUotyping of C3bR on Erythrocytes.  C3bR phenotyping was  performed as previously 
described  (5)  using  blood  samples  collected  in  standard  ACD  (acid-citrate-dextrose, 
formula A) anticoagulant. Briefly, erythrocytes were surface labeled with ~2~I and solubi- 
lized with 1% NP-40. Samples were then immunoprecipitated with a monoclonal antibody 
against C3bR and analyzed by slab gel SDS-polyacrylamide gel electrophoresis according 
to the method of Laemmli using a 5% gel and autoradiography. 
Allotyping of HLA Antigens.  Typing of HLA-A, -B, and -C antigens was done by the 
standard National Institutes of Health cytotoxicity technique modified so that the reading 
was by the contrast fluorescence technique developed in this laboratory (9).  Typing of 
HLA-DR antigens was done by the two-color fluorescence test described by van Rood et 
al. (10). All currently recognized HLA-A, -B, -C, and -DR antigens were identifiable with 
the sera (n =  204) in our routine battery. 
Allotyping of  C3.  The procedure for testing this polymorphic protein was a modification 
of a previously described test (11). 
Linkage Analysis.  Segregation data for the different variants fit Mendelian expecta- 
tions.  Analysis  of linkage was  done with  the  Lod score method of Morton using the 
NYLIP  computer  program  developed in  this  laboratory (12).  Confirmation  of these 
findings was done with the newly described method of multilocus analysis of linkage (13) 
using the LINKAGE computer program (14) kindly provided by Dr. J. M. Lalouel. 
Results and Discussion 
This report demonstrates  the  existence in  humans  of a  cluster of genes  for 
complement proteins that constitute the regulatory counterparts of the  MHC- 
linked cluster of C3 convertase components genes. We have previously demon- 
strated that the C4BP and C3bR loci are linked in humans (7): no recombinants 
have been encountered between C4BP and C3bR in informative heterozygotes. 
We also reported that the less common allele C4BP*2 is only found in haplotypes 
that also contain the less frequent allele C3bR*B, as shown by segregation studies 
in three pedigrees. Recently, a  further individual with the genotype C3bR*B,B; 
C4BP*I,2  was  identified  in  a  Dutch  family.  The  complete  inclusion  of  the 
C4BP*2 allele in the C3bR *B haplotype demonstrates the presence of very strong 
linkage disequilibrium. This fact, in addition to the linkage data, indicates that 
the loci coding for C4-bp and C3bR  must be closely linked. The more recently 
found polymorphism of factor H could, therefore, be analyzed for linkage to the 
haplotypes defined by C4BP  and  C3bR  alleles,  thus  increasing  the  number  of 
informative families. RODR1GUEZ  DE  CORDOBA  ET  AL. 
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FmURE  1.  Linkage analysis between FH locus and the C3bR, C4BP linkage group..Maximum 
likelihood estimate of recombination fraction, 0, is 0.043, with corresponding maximum Lod 
score of 3.035. 
Seven two-generation families, with a total of 39 members, each contained one 
parent who was heterozygous both at the FH locus and at the C3bR-C4BP region 
(i.e., C3bR- and/or C4BP-heterozygous).  There were 23 informative meioses in 
these families with only one recombinant. The values for the Lod score (logarithm 
of odds in favor of linkage) were calculated for different values of the recombi- 
nant fraction,  0, using the NYLIP program  (Fig.  I). The maximum  Lod score 
value was estimated  to be 3.035  (i.e.,  the odds on  linkage  are  1,084:1)  at a  0 
value of 0.043 (i.e., 4.3. centimorgans [cM]). The only recombinant between FH 
and  the C3bR-C4BP region  belongs to a  large pedigree (family PED) in which 
the father is a  triple heterozygote C3bR*A,B; C4BP'1,2; FH*I,2 (Fig. 2). This 
crossing-over event defines the position of the FH gene as separable from the 
other two genes in  the cluster.  The  estimated  distance  (4.3  cM) is,  of course, 
only approximate because of the scarcity of data. 
These results have been confirmed by muitilocus linkage analysis, developed 
by Meyers  et  al.  (13),  which  also  allowed  us  to  derive  information  from  an 
additional family with five offspring that was informative for the segregation of 
the  C4BP and  C3bR  loci.  According  to  this  approach,  likelihood  ratios  from 
pedigrees  with  a  double-heterozygote parent  (and  hence  informative  for only 
one of the three possible pairs of loci) were combined with data from families 
with a triple-heterozygote parent.  Maximum likelihood estimates were made for 
the  recombination  fractions  under  each  of  the  three  possible  gene  orders. 
(Parameters included the coefficient of coincidence c, a measure of interference 
in crossing-over; the results gave no evidence for interference,  with maximum 
likelihood occurring at the boundary value, c =  1.) The most likely gene order 
was either C4BP-C3bR-FH or C3bR-C4BP-FH, with Oc4ne.cabR =  0.000 and OC4BP,FH 1192  A  "NEW"  GENE  CLUSTER  CONTROLLING COMPLEMENT  COMPONENTS 
FIGURE 2.  Pedigree  of family PED  showing C3bR, C4BP, and  FH genotypes.  Assigned 
haplotypes are A-l-I/B-l-1 for the mother and A-1-2/B-2-1 for the father. Note that sibling 
8 (*) represents a cross-over between C3bR, C4BP on one side and FH on the other. Phenotypes 
for C3bR, C4BP, and FH were determined  as described in Materials and Methods. Parental 
phenotypes are shown at the bottom of the figure for paternal (Fa) and maternal (Mo) samples. 
=  0.044, as before, with a  likelihood ratio in favor of linkage of 2.77  x  105 to  1. 
In accord with  large-sample theory (15),  2  Ioge (likelihood ratio) is a  ×2 variate 
with two degrees of freedom, giving P  <  10  -5 for this triple-linkage group. These 
findings,  therefore,  define a  new linkage group in  man, consisting of the  regu- 
latory proteins C3bR, C4-bp, and H  of the complement system. They also provide 
information in relation to the ordering of the three loci. 
We have previously reported that neither C4BP (3) nor C3bR (16) are closely 
linked  to  the  HLA-linked  gene  cluster  encoding  the  complement  components 
C2, B, C4A, and C4B. These results are now updated and summarized in Table 
I, which indicates that the C4BP, C3bR, FH gene cluster segregates independently 
of the C2, Bf, C4A, C4B gene cluster, the TCA locus  ~ and the C3 locus. 
The three proteins studied here,  C3bR, C4-bp, and H, regulate the activities 
of the classical and/or alternative pathway C3 convertases. They all cause decay 
acceleration  of  these  enzymes  and  serve  as  cofactors  for  factor  I-mediated 
cleavage  of  C4b  and/or  C3b.  As  members  of  a  linkage  group,  they  form 
2 TCA, a  locus ~10  cM  telomeric  to HLA-A, codes for class I  antigens  in  the  surface  of T 
lymphocytes and is probably homologous to the Qa locus in the mouse (17). RODRIGUEZ  DE  CORDOBA  ET  AL.  1193 
TABLE  I 
Lod Score Values  for Linkage Between HLA, C3, or TCA Loci and RCA * 
Loci 
Number of  Nonre-  Lod score at 0 = 
informa-  combinant/ 
tive fami-  recombi-  0.0  0.05  0.10  0.15  0.20  0.25  0.30 
lies  nant* 
HLA:RCA  42  103:42  -00  -23.07  -12.74  -6.87  -3.77  -1.91  -0.90 
C3:RCA  11  23:10  -00  -5.63  -3.07  -1.79  -1.03  -0.57  -0.29 
TCA:RCA  6  14:6  -00  -3.51  -1.94  -1.13  -0.64  -0.34  -0.15 
* HLA, human leukocyte antigens; TCA, T  cell A locus; RCA, regulators of complement activation; 
C3, locus encoding the third complement component. 
* Under the assumption of linkage. 
haplotypes analogous to the "complotypes" of Alper et al. (18), composed of the 
four closely linked loci for the complement proteins, C2, B, C4A, and C4B. The 
alleles  of C3bR,  C4BP, and  FH will therefore  be  referred  to as  regulators of 
complement activation (RCA) haplotype. Both the complotype gene cluster and 
the RCA gene cluster reported here consist of functionally related proteins; the 
complotype cluster consists of elements of a C3 convertase, the RCA cluster, of 
regulatory proteins for C3 convertase. Linkage disequilibrium is present between 
several pairs of complotype alleles (18), and also between the RCA alleles C4BP*2 
and C3bR*B. Larger groups of unrelated people will need to be phenotyped to 
determine RCA haplotype frequencies and to ascertain whether there is additional 
linkage disequilibria in this group. The biological significance of this new com- 
plement gene cluster, perhaps in determining disease susceptibility, remains to 
be ascertained. In view of the proposed regulation of the trafficking of C3- and 
C4-bearing immune complexes (19) and the findings of abnormalities of these 
proteins in systemic lupus erythematosus (20-22),  further understanding of the 
genetics and function of this system of linked loci should provide insights into 
the control of putative immune complex-mediated illnesses. 
It is interesting that the genes coding for most of the complement components 
are arranged in clusters and that the two other linkage groups described thus far 
for human complement components (i.e., C2-Bf-C4A-C4B and C6-C7) have been 
extremely well preserved throughout evolution (1, 2, 23-25).  The RCA system 
should, therefore, also be investigated from this viewpoint. An apparently incon- 
sistent situation might exist in mice because C4BP was shown to be located within 
the H-2D-Qa interval  (26,  27) while FH segregated independently of the H-2 
system (28). This would indicate that C4BP and FH are not linked in the mouse. 
However, we have recently presented data disputing the assignment of C4BP to 
the H-2 region  (29).  Thus,  the issue  of the  evolutionary conservation of this 
genetic unit remains unsettled. 
This linkage group is also of interest because two of the proteins, C4-bp and 
H, are plasma glycoproteins synthesized and secreted by hepatocytes, while the 
other, C3bR, is an integral membrane glycoprotein characteristically found on 
erythrocytes and leukocytes. The functional similarity and genetic relationship 
among these molecules may well be due to their being encoded by genes with a 
common ancestral  origin (7).  This hypothesis, however, implies the additional 
existence of a  significant  structural  homology, for  which there  are  no direct 1194  A  "NEW" GENE CLUSTER  CONTROLLING COMPLEMENT COMPONENTS 
supporting data.  On the other hand, whether or not this cluster was formed in 
that  fashion,  its  existence may relate to possible  evolutionary consequences of 
the close  linkage.  Close  linkage,  for example,  may favor the  evolution of the 
genetic  mechanisms  for the  control of the  integrated expression  of the  genes 
within  the cluster,  and  thereby influence the homeostatic adaptability of their 
carriers. 
Summary 
A  new cluster of complement component genes, including C4BP,  C3bR,  and 
FH, is described. Family segregation data indicate that FH is linked to the genes 
for C4-bp and C4bR, previously reported to be linked and to maintain  linkage 
disequilibrium. This cluster is not linked to the major histocompatibility complex, 
which contains the genes for the complement components, C4, C2, and factor 
B, or to the C3 locus. These data further suggest that the organization of genes 
for functionally related proteins in clusters may be a  rule for the complement 
system. 
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